1. Home
  2. BWEN vs KZIA Comparison

BWEN vs KZIA Comparison

Compare BWEN & KZIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Broadwind Inc.

BWEN

Broadwind Inc.

HOLD

Current Price

$2.41

Market Cap

51.0M

Sector

Industrials

ML Signal

HOLD

Logo Kazia Therapeutics Limited

KZIA

Kazia Therapeutics Limited

HOLD

Current Price

$6.16

Market Cap

56.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BWEN
KZIA
Founded
N/A
1994
Country
United States
Australia
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
51.0M
56.8M
IPO Year
2009
2002

Fundamental Metrics

Financial Performance
Metric
BWEN
KZIA
Price
$2.41
$6.16
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$6.00
$17.67
AVG Volume (30 Days)
247.6K
223.7K
Earning Date
05-09-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.27
N/A
Revenue
$146,785,000.00
N/A
Revenue This Year
$11.75
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$8.93
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.41
$0.64
52 Week High
$4.15
$17.40

Technical Indicators

Market Signals
Indicator
BWEN
KZIA
Relative Strength Index (RSI) 37.91 46.80
Support Level $2.29 $4.91
Resistance Level $2.49 $6.34
Average True Range (ATR) 0.20 0.56
MACD -0.02 0.11
Stochastic Oscillator 25.00 66.69

Price Performance

Historical Comparison
BWEN
KZIA

About BWEN Broadwind Inc.

Broadwind Inc is a precision manufacturer of structures, equipment and components for clean technology and other specialized applications. The company provide technologically high value products to customers with complex systems and stringent quality standards that operate in energy, mining and infrastructure sectors, in the United States of America. It capabilities include heavy fabrications, welding, metal rolling, coatings, gear cutting and shaping, gearbox manufacturing and repair, heat treat, assembly, engineering and packaging solutions. It operates through four operating segments namely Heavy Fabrications, Gearing, Industrial Solutions and Corporate.

About KZIA Kazia Therapeutics Limited

Kazia Therapeutics Ltd is a biotechnology company focused on pharmaceutical drug development in oncology. The company has a portfolio of development candidates across various technologies targeting multiple cancer indications. Its primary program is Paxalisib, an investigational brain-penetrant inhibitor of the PI3K/Akt/mTOR pathway, designed for the treatment of brain cancer. The company develops targeted therapies aimed at addressing medical needs in oncology. The company operates in Australia and the United States.

Share on Social Networks: